3
Researchers have identified and further developed novel antibody fragments against the SARS coronavirus-2. These ‘nanobodies’ are smaller than classic antibodies penetrating the tissue better and can be produced in larger quantities. The researchers also combined the nanobodies into potentially particularly effective molecules attacking different parts of the virus simultaneously. The approach could prevent the pathogen from evading the active agent through mutations.